“Conclusions Our data demonstrate the development of tolerance and early attenuation of effect on left ventricular filling pressure with frequent oral dosing Q 4 and Q 6 hours) with ISDN in patients with chronic CHF, which may be related to persistently elevated trough blood levels of ISDN.”